BioSpace News Archive

Crinetics Pharmaceuticals today announced that company management will participate in the following investor conferences in the month of September: H.C. Wainwright: 23rd Annual Global Investment Conference (September 13-15, 2021)

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) is pleased to announce that it has confirmed in its own preclinical study, that AP-188 (“N,N-Dimethyltryptamine or “DMT”), increased the growth of cortical neurons by 40% with statistical significance in one arm of the study, when compared to control.

Mindset Pharma Inc. today announced that it has developed first-in-class studies to enable the Company to confirm the psychedelic effect of its novel compounds with greater accuracy.

Genomma Lab Internacional, S.A.B. de C.V. today announced that the Mexican Ministry of Health’s Federal Committee for Protection from Sanitary Risks (“COFEPRIS”) has granted “Good Manufacturing Practices” (GMP) certification for Genomma Lab’s Medicinas y Medicamentos Nacionales, S.A. de C.V. (“MMN”) solids and semi-solids manufacturing facility in the State of Mexico.

Nuvo Pharmaceuticals Inc. (TSX:MRV) (OTCQX:MRVFF) d/b/a Miravo Healthcare today announced it will be featured as a presenting company at the H.C. Wainwright 23rd Annual Global Investment Conference. The conference is being held as a virtual conference on September 13-15, 2021.

Citius Pharmaceuticals, Inc. today announced that it has entered into a definitive agreement with Dr. Reddy’s Laboratories SA, a subsidiary of Dr. Reddy’s Laboratories, Ltd.

Infinity Pharmaceuticals, Inc. today announced the appointment of Robert Ilaria, Jr., M.D. as Chief Medical Officer. In addition, Brian Schwartz, M.D., will be transitioning from his role as Consulting Chief Physician to the Infinity Board of Directors.

Premier, Inc. (NASDAQ: PINC) today announced it has decreased the size of its Board of Directors from 15 to 11, effective August 31, 2021, to further enhance the company’s governance profile.

Titan Medical Inc. today announced that David McNally, President and CEO of Titan Medical, will present an overview of the company and its Enos™ robotic single access surgical system at the H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13, 2021.

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced that Bill Lundberg, M.D., Chief Executive Officer of Merus, will participate in the following investor conferences.